Liquid Dosage

Monoclonal Antibodies

GEA is a leading specialist in the field of process equipment for liquid processing and metering for the pharmaceutical and biotech industries, including fermentation plant for the manufacture of products such as monoclonal antibodies (mAbs) for diagnostic and therapeutic purposes.

Monoclonal antibodies are known as targeted therapies because they work by targeting specific proteins on the surface of cells. Successfully used to treat cancers, tumors and other serious diseases, mAbs are — compared with other biopharmaceutical products — large proteins that require relatively high administration doses and traditionally necessitate high-volume manufacturing equipment/systems and facilities. GEA offers production systems for monoclonal antibodies that are produced in state-of-the-art stainless steel bioreactors by specific cell cultures.

From Culture to Harvest

The cell culture process is done in several steps, starting with 10 L precultures and successively cultivating intermediate batches up to a final production volume of up to 20,000 L. These systems comprise the vessel, with the stirrer as the core element, and peripherals such as temperature control systems, clean-in-place (CIP) components, aeration and deaeration systems, input systems and automated sensors, actuators and the operator interface. 

Support processes, such as media preparation and harvest systems are also available from GEA. The process integration of separators and filters for the harvest step is also within GEA’s scope of service. Because of the high sensitivity of the cells and the need for operator and product safety, all GEA system components are designed according to the latest standards and have the highest grade of finish quality.

Downloads

GEA 洞察

定制挤奶设备支持奶牛和农场主的福祉

健康快乐的奶牛是成功和可持续牛奶生产的关键。因此,保持奶牛健康是每个奶农努力的核心。奶牛的健康受到许多因素影响,例如根据奶牛个体需求进行适当喂养、良好的饲养条件以及新鲜的空气、水和光照。而且,挤奶方式对奶牛的健康状况也有很大的影响。GEA 因其“优质挤奶理念”而闻名,不断致力于进一步发展,并在动物健康和牛奶质量方面取得更好的成果。

利用 GEA 的整体工程解决方案实现净零排放

各行各业都在努力实现净零排放目标,同时遵守严格的脱碳法规和立法。与此同时,公司必须平衡日益增长的质量、产品开发和工艺优化需求,此外,还必须努力提高盈利能力。应对这一挑战需要采取 GEA 提供的协作和整体方法。

在餐桌上享用…新食品:打造我们食品的未来

咖啡、可可、牛奶、肉类、鱼类和蛋类 - 这些日常主食在很大程度上依赖集约农业。随着新食品技术的兴起,我们有了更多可持续的替代品。我们采访了 GEA 液体、发酵和灌装部门的高级副总裁 Reimar Gutte 博士,探讨其中的可能性和政策。

接收 GEA 新闻

订阅 GEA 的新闻,掌握 GEA 的创新信息和故事。

联系我们

我们随时为您提供帮助!您只需提供少量详细信息,我们就能回复您的查询。